0Suppliers
4Customers
3Debt Items
12Related Chains

Bolt Biotherapeutics, Inc. Suppliers

No suppliers on recordBolt Biotherapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Bolt Biotherapeutics, Inc. Customers

TickerNameConfidenceEvidence
GENMAB GENMAB 90% The Company determined that the Genmab Agreement is a contract with a customer and should be accounted for under ASC 606.
TORAY-INDUSTRIES-INC TORAY-INDUSTRIES-INC 90% The Company determined that the Toray Agreement is a contract with a customer and should be accounted for under ASC 606.
GNMSF Genmab A/S 85% s covered under the agreement as a whole. Such optional additional items will be accounted for as contract modifications when development advances past certain milestones and the parties both exercis…
GNMSF Genmab A/S 85% Reciprocal relationship from GNMSF graph: Reciprocal relationship from BOLT graph: Reciprocal relationship from GNMSF graph: Reciprocal relationship from BOLT graph: s covered under the agreement as …

Bolt Biotherapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BOLT-DEBT-8324 Warrants outstanding: 0.07 90% xbrl warrant detail from xbrl 2018-07-31.
BOLT-DEBT Debt stack $22.3M 90% Market cache reports total debt of $22.3M.
BOLT-DEBT-8325 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.

Bolt Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bolt Biotherapeutics, Inc..

Bolt Biotherapeutics, Inc. Ownership

HolderNameConfidenceEvidence
BOLT-OWNER-VIVO-CAPITAL-LLC Vivo Capital, LLC 90% 13F overlay lists Vivo Capital, LLC as top holder; 24 tracked holders.

Bolt Biotherapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IMTX Immatics N.V. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
GMAB Genmab A/S 100.00 2
GHRS GH Research PLC 100.00 2
JNJ Johnson & Johnson 100.00 2
GENMAB GENMAB 60.75 1 ['receiving']
SNYNF Sanofi 50.00 2
CNTA Centessa Pharmaceuticals plc 50.00 2
GNMSF Genmab A/S 45.90 1 ['customer']
MGNX MacroGenics, Inc. 17.45 2